HealthCor Catalio Acquisition Corp. Form 8-K Summary
Business context and reporting period
The filing reports events beginning January 26, 2021, including the effectiveness of the company’s IPO registration statements and related agreements. Although the request identifies Hyperfine, Inc., the registrant named in this filing is HealthCor Catalio Acquisition Corp., a Cayman Islands special purpose acquisition company (SPAC). The IPO was consummated on January 29, 2021.
Key financial and capital-market metrics
- The company sold 20,700,000 Class A ordinary shares to the public at $10.00 per share, generating gross IPO proceeds of $207.0 million.
- The IPO amount included the underwriters’ full exercise of their 2,700,000-share over-allotment option.
- The sponsor purchased 614,000 Class A ordinary shares in a private placement at $10.00 per share, generating $6.14 million of proceeds.
- Net proceeds from the IPO and specified private-placement proceeds were to be held in a trust account. The filing text does not provide a clear value for net proceeds after underwriting discounts, offering expenses, or other costs.
- The filing does not provide operating revenue, profit, cash flow, margins, debt balances, or liquidity beyond the IPO and private-placement proceeds.
Material changes and agreements
- The company entered into an underwriting agreement with Jefferies LLC.
- The company established a trust account under an Investment Management Trust Agreement with Continental Stock Transfer & Trust Company.
- The sponsor and certain equityholders received registration and shareholder rights, including customary demand and piggy-back registration rights. Following a business combination, the sponsor will have the right to nominate three individuals for election to the board.
- The sponsor, executive officers, and directors agreed to vote their shares in favor of the initial business combination, subject to the agreement’s terms.
- The amended and restated memorandum and articles of association were adopted in connection with the IPO.
- The sponsor agreed to provide office space and administrative services for up to $10,000 per month until the earlier of completion of the initial business combination or liquidation.
Outlook, risks, contingencies, and unusual items
- The company is a SPAC and had not reported an operating business or completed an initial business combination in this filing.
- The letter agreement requires the company to facilitate liquidation if an initial business combination is not completed within 24 months of the relevant date.
- The sponsor’s private-placement shares are subject to transfer restrictions until 30 days after completion of the initial business combination, subject to limited exceptions.
- The company agreed not to enter into a definitive initial business-combination agreement without the sponsor’s prior consent.
- Future liquidity and investor returns depend substantially on identifying and completing an initial business combination; the filing does not provide a specific target, valuation, or transaction timeline.
Important facts for investors to verify
- Verify the registrant identity and the distinction between HealthCor Catalio Acquisition Corp. and Hyperfine, Inc.
- Review the IPO underwriting agreement, trust agreement, private-placement agreement, letter agreement, and amended organizational documents filed as exhibits.
- Confirm the trust-account balance and the amount of net IPO proceeds after offering expenses.
- Review the proposed business-combination deadline, redemption rights, dilution provisions, and liquidation terms in the governing documents.
- Confirm whether a subsequent filing identifies a target business combination or changes the company’s name, capitalization, or trading symbol.